rTMS of supplementary motor area modulates therapy-induced dyskinesias in Parkinson disease

Neurology. 2005 Aug 23;65(4):623-5. doi: 10.1212/01.wnl.0000172861.36430.95.

Abstract

The neural mechanisms and circuitry involved in levodopa-induced dyskinesia are unclear. Using repetitive transcranial magnetic stimulation (rTMS) over the supplementary motor area (SMA) in a group of patients with advanced Parkinson disease, the authors investigated whether modulation of SMA excitability may result in a modification of a dyskinetic state induced by continuous apomorphine infusion. rTMS at 1 Hz was observed to markedly reduce drug-induced dyskinesias, whereas 5-Hz rTMS induced a slight but not significant increase.

Publication types

  • Clinical Trial

MeSH terms

  • Aged
  • Apomorphine / adverse effects*
  • Dopamine / physiology
  • Dopamine Agonists / adverse effects
  • Dyskinesia, Drug-Induced / physiopathology
  • Dyskinesia, Drug-Induced / therapy*
  • Female
  • Humans
  • Male
  • Middle Aged
  • Motor Cortex / physiology*
  • Motor Cortex / physiopathology
  • Neural Pathways / physiology
  • Neural Pathways / physiopathology
  • Parkinson Disease / drug therapy
  • Parkinson Disease / physiopathology
  • Recovery of Function / physiology
  • Transcranial Magnetic Stimulation / methods*
  • Treatment Outcome

Substances

  • Dopamine Agonists
  • Apomorphine
  • Dopamine